ANN ARBOR STAGE IB HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IB HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IB HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IB HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for older hodgkin patients: Chemo-Free combo shows promise
Disease control OngoingThis study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 and older (or younger people who cannot tolerate standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see if this drug pair can shrink or eliminate the cancer witho…
Matched conditions: ANN ARBOR STAGE IB HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 26, 2026 10:06 UTC
-
Smart scan guides lymphoma therapy, spares unneeded drugs
Disease control OngoingThis study tests a personalized approach for people with early-stage Hodgkin lymphoma (stages I-II). Doctors use PET scans to see how well the cancer responds to initial chemotherapy, then adjust the treatment plan—adding or skipping certain drugs—to improve outcomes and reduce s…
Matched conditions: ANN ARBOR STAGE IB HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 07, 2026 18:43 UTC